لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Estephan LE; Department of Otolaryngology - Head and Neck Surgery, Thomas Jefferson University Hospitals, Philadelphia, PA, United States., Kumar G; Sidney Kimmel Cancer Center, Thomas Jefferson University Hospitals, Philadelphia, PA, United States.; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, United States., Stewart M; Department of Otolaryngology - Head and Neck Surgery, Thomas Jefferson University Hospitals, Philadelphia, PA, United States.; Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH, United States., Banoub R; Department of Otolaryngology - Head and Neck Surgery, Thomas Jefferson University Hospitals, Philadelphia, PA, United States., Linnenbach A; Sidney Kimmel Cancer Center, Thomas Jefferson University Hospitals, Philadelphia, PA, United States.; Department of Pharmacology, Physiology and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, United States., Harshyne LA; Sidney Kimmel Cancer Center, Thomas Jefferson University Hospitals, Philadelphia, PA, United States.; Department of Medical Oncology, Thomas Jefferson University Hospitals, Philadelphia, PA, United States., Martinez-Outschoorn UE; Sidney Kimmel Cancer Center, Thomas Jefferson University Hospitals, Philadelphia, PA, United States.; Department of Medical Oncology, Thomas Jefferson University Hospitals, Philadelphia, PA, United States., Mahoney MG; Department of Otolaryngology - Head and Neck Surgery, Thomas Jefferson University Hospitals, Philadelphia, PA, United States.; Department of Pharmacology, Physiology and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, United States., Curry JM; Department of Otolaryngology - Head and Neck Surgery, Thomas Jefferson University Hospitals, Philadelphia, PA, United States.; Sidney Kimmel Cancer Center, Thomas Jefferson University Hospitals, Philadelphia, PA, United States., Johnson J; Department of Otolaryngology - Head and Neck Surgery, Thomas Jefferson University Hospitals, Philadelphia, PA, United States.; Sidney Kimmel Cancer Center, Thomas Jefferson University Hospitals, Philadelphia, PA, United States.; Department of Medical Oncology, Thomas Jefferson University Hospitals, Philadelphia, PA, United States., South AP; Sidney Kimmel Cancer Center, Thomas Jefferson University Hospitals, Philadelphia, PA, United States.; Department of Pharmacology, Physiology and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, United States., Luginbuhl AJ; Department of Otolaryngology - Head and Neck Surgery, Thomas Jefferson University Hospitals, Philadelphia, PA, United States.; Sidney Kimmel Cancer Center, Thomas Jefferson University Hospitals, Philadelphia, PA, United States.

المصدر: Frontiers in oncology [Front Oncol] 2024 Jun 18; Vol. 14, pp. 1412212. Date of Electronic Publication: 2024 Jun 18 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

المؤلفون: Alnemri AE; Department of Otolaryngology - Head & Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Tekumalla S; Department of Otolaryngology - Head & Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Moroco AE; Department of Otolaryngology - Head & Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Vathiotis I; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Tuluc M; Department of Pathology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Gargano S; Department of Pathology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Zhan T; Department of Biostatistics, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Cognetti DM; Department of Otolaryngology - Head & Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Curry JM; Department of Otolaryngology - Head & Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Argiris A; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Linnenbach A; Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., South AP; Department of Otolaryngology - Head & Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.; Department of Pharmacology, Physiology and Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Harshyne LA; Department of Microbiology & Immunology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Johnson JM; Department of Otolaryngology - Head & Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Luginbuhl AJ; Department of Otolaryngology - Head & Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

المصدر: Cancer medicine [Cancer Med] 2024 Jun; Vol. 13 (11), pp. e7370.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE

مواضيع طبية MeSH: Squamous Cell Carcinoma of Head and Neck*/drug therapy , Squamous Cell Carcinoma of Head and Neck*/blood , Squamous Cell Carcinoma of Head and Neck*/immunology , Immune Checkpoint Inhibitors*/adverse effects , Immune Checkpoint Inhibitors*/therapeutic use , Neoadjuvant Therapy*/adverse effects , Neoadjuvant Therapy*/methods , Cytokines*/blood , Head and Neck Neoplasms*/drug therapy , Head and Neck Neoplasms*/blood , Head and Neck Neoplasms*/immunology, Humans ; Male ; Female ; Middle Aged ; Retrospective Studies ; Aged ; Nivolumab/adverse effects ; Nivolumab/therapeutic use

المؤلفون: Hill BL; Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Calder AN; Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.; Drexel University College of Medicine, Philadelphia, Pennsylvania, USA., Flemming JP; Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Guo Y; Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Gilmore SL; Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Trofa MA; Sidney Kimmel Medical School, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Daniels SK; Sidney Kimmel Medical School, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Nielsen TN; John A. Burns School of Medicine, University of Hawai'i at Mānoa Honolulu, Honolulu, USA., Gleason LK; Sidney Kimmel Medical School, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Antysheva Z; BostonGene Corporation, Waltham, Massachusetts, USA., Demina K; BostonGene Corporation, Waltham, Massachusetts, USA., Kotlov N; BostonGene Corporation, Waltham, Massachusetts, USA., Davitt CJH; BostonGene Corporation, Waltham, Massachusetts, USA., Cognetti DM; Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Prendergast GC; Lankenau Institute for Medical Research, Wynnewood, Pennsylvania, USA., Snook AE; Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Johnson JM; Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Kumar G; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Linnenbach AJ; Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Martinez-Outschoorn U; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., South AP; Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.; Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Curry JM; Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Harshyne LA; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Luginbuhl AJ; Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Mahoney MG; Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.; Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

المصدر: Molecular carcinogenesis [Mol Carcinog] 2023 Sep; Vol. 62 (9), pp. 1428-1443. Date of Electronic Publication: 2023 Jul 04.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8811105 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-2744 (Electronic) Linking ISSN: 08991987 NLM ISO Abbreviation: Mol Carcinog Subsets: MEDLINE

مواضيع طبية MeSH: Papillomavirus Infections* , MicroRNAs*/genetics , MicroRNAs*/metabolism , Head and Neck Neoplasms*/drug therapy , Head and Neck Neoplasms*/genetics , Extracellular Vesicles*/metabolism, Humans ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; Squamous Cell Carcinoma of Head and Neck/genetics ; Interleukin-8/genetics ; Nivolumab/pharmacology ; Nivolumab/therapeutic use ; Neoadjuvant Therapy

المؤلفون: Johnson JM; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA Jennifer.M.Johnson@Jefferson.edu.; Department of Otolaryngology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Vathiotis IA; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Harshyne LA; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA., Ali A; Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Bar Ad V; Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Axelrod R; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Lorber E; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Curry J; Department of Otolaryngology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Cognetti DM; Department of Otolaryngology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Luginbuhl AJ; Department of Otolaryngology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Tuluc M; Department of Pathology, Anatomy, and Cell Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Keith S; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Mahoney MG; Department of Otolaryngology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.; Department of Dermatology and Cuaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Argiris A; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Aug; Vol. 11 (8).

نوع المنشور: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Nivolumab*/pharmacology , Nivolumab*/therapeutic use , Head and Neck Neoplasms*/drug therapy, Humans ; Ipilimumab/pharmacology ; Ipilimumab/therapeutic use ; B7-H1 Antigen ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use

المؤلفون: Herbst C; Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA, United States., Harshyne LA; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA, United States., Igyártó BZ; Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA, United States.

المصدر: Frontiers in immunology [Front Immunol] 2022 Oct 27; Vol. 13, pp. 1053582. Date of Electronic Publication: 2022 Oct 27 (Print Publication: 2022).

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Exosomes* , Extracellular Vesicles*, Dendritic Cells ; Cell Communication ; Adaptive Immunity